BioLife Solutions (BLFS) Misses Q4 EPS by 1c; Offers FY19 Revenue Mid-Point Guidance Above Consensus

Go back to BioLife Solutions (BLFS) Misses Q4 EPS by 1c; Offers FY19 Revenue Mid-Point Guidance Above Consensus

BioLife Solutions Announces Fourth Quarter and Full Year 2018 Financial Results

March 14, 2019 4:05 PM EDT

BOTHELL, Wash., March 14, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife"), the leading developer, manufacturer and marketer of proprietary cell and tissue hypothermic... More